https://m2.mtmt.hu/ hun 2026-09-21 21:39 JournalArticle 34109310 VALIDATED true 0 false 2026-08-04T08:54:16.020+0000 2024-04-17T14:12:37.837+0000 2023-08-24T09:05:35.680+0000 true 10065463 Turek Márta /api/admin/10065463 Admin Turek Márta (KOKI admin 4) true 2026-08-26T10:17:52.320+0000 2026-08-26T10:17:52.320+0000 2024-04-17T14:12:38.234+0000 true 10025544 Lévayné Deseő Katalin /api/admin/10025544 Admin Lévayné Deseő Katalin (MTMT Központi admin) true 10025544 Admin 10066925 /api/admin/10066925 Nemec Évi (MTMT Központi 3, admin) Nemec Évi true true Admin 10067876 /api/admin/10067876 Ladányi Gusztáv (MTMT API user, admin) Ladányi Gusztáv true true 2024-10-17T16:20:19.023+0000 true false true 24 24 /api/publicationtype/24 PublicationType Folyóiratcikk 1 true 24 JournalArticle true 10000059 Article true 24 24 /api/publicationtype/24 PublicationType Folyóiratcikk 1 true 24 JournalArticle /api/subtype/10000059 Szakcikk SubType Szakcikk (Folyóiratcikk) 101 true 10000059 true 1 /api/category/1 Category Tudományos true 1 Huang, Lumei true true /api/journal/10088725 REVIEWED ISCIENCE 2589-0042 true false 10088725 false 10088725 true 2589-0042 Journal FOREIGN 26 9 107560 107560 24 2023 Funding 2039200 /api/funding/2039200 Nemzeti Gyógyszerkutatási és Fejlesztési Laboratórium (PharmaLab)(RRF-2.3.1-21-2022-00015) Támogató: NKFIH false true Funding 2036046 /api/funding/2036046 National Laboratory of Translational Neuroscience(RRF-2.3.1-21-2022-00015) false true Funding 2030143 /api/funding/2030143 Recovery and Resilience Facility of the European Union within the framework of Programme Szécheny...(RRF-2.3.1-21-2022-00011) false true Funding 2036045 /api/funding/2036045 National Laboratory of Translational Neuroscience (TINL)(RRF-2.3.1-21-2022-00011) false true Funding 2030141 /api/funding/2030141 Hungarian Research and Development Fund(131629) false true Funding 2030142 /api/funding/2030142 Hungarian Brain Research Program(NAP2022-I-1/2022) false true Funding 2030144 /api/funding/2030144 European Union’s Horizon 2020 Research and Innovation Program under the Marie Skłodowska Curie(766124) false true true true 2023 true true true false true false GOLD 2026-08-04 true https://doi.org/10.1016/j.isci.2023.107560 9 0 9 9 0 9 9 8 9 9 9 9 9 9 0 0 9 9 9 9 0 10 10 Folyóiratcikk Journal Article 24 8 Könyvrészlet Chapter in Book 25 1 Könyv Book 23 0 Egyéb konferenciaközlemény Conference paper 31 0 Egyéb konferenciakötet Conference proceedings 32 0 Oltalmi formák Protection forms 26 0 Disszertáció Thesis 28 0 Egyéb Miscellaneous 29 0 Alkotás Achievement 22 0 Kutatási adat Research data 33 0 Folyóiratcikk Journal Article 24 0 0 0 Könyvrészlet Chapter in Book 25 0 0 0 Könyv Book 23 0 0 0 Egyéb konferenciaközlemény Conference paper 31 0 0 0 Egyéb konferenciakötet Conference proceedings 32 0 0 0 Oltalmi formák Protection forms 26 0 0 0 Disszertáció Thesis 28 0 0 0 Egyéb Miscellaneous 29 0 0 0 Alkotás Achievement 22 0 0 0 Kutatási adat Research data 33 0 0 0 2024 0 1 1 1 1 2025 0 2 2 2 2 2026 0 6 6 6 6 D1 false 10008942 false false false 2023-08-27T11:42:13.123+0000 Celluláris Neurofarmakológia Kutatócsoport (HRN KOKI); Doktori Iskola (SE); Kísérleti Orvostudományi Kutatóintézet; Molekuláris Farmakológia Kutatócsoport (HRN KOKI); Molekuláris Neurobiológiai Kutatócsoport (HRN KOKI) 10 48 5 10 0 true 10066925 10067876 Language 10002 /api/language/10002 Angol Angol English true 2 true PersonAuthorship 109675864 /api/authorship/109675864 Huang, Lumei [Huang, Lumei (Institute of expe...), szerző] Doktori Iskola (SE); Molekuláris Farmakológia Kutatócsoport (HRN KOKI); Kísérleti Orvostudományi Kutatóintézet 1 0.1 true false false Author 10070293 /api/author/10070293 Huang Lumei (Institute of experimental medicine) Huang Lumei true true Huang Lumei true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 109675865 /api/authorship/109675865 Mut-Arbona, Paula [Mut-Arbona, Paula (Neuroscience), szerző] Doktori Iskola (SE); Molekuláris Farmakológia Kutatócsoport (HRN KOKI); Kísérleti Orvostudományi Kutatóintézet 2 0.1 false false false Author 10071685 /api/author/10071685 Mut-Arbona Paula (Neuroscience) Mut-Arbona Paula true true Mut-Arbona Paula true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 109675866 /api/authorship/109675866 Varga, Bernadett [Iring-Varga, Bernadett (funkcionális ideg...), szerző] Doktori Iskola (SE); Molekuláris Farmakológia Kutatócsoport (HRN KOKI); Kísérleti Orvostudományi Kutatóintézet 3 0.1 false false false Author 10076833 /api/author/10076833 Iring-Varga Bernadett (funkcionális idegtudomány) Iring-Varga Bernadett true true Varga Bernadett true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 109675867 /api/authorship/109675867 Török, Bibiana [Szocsics-Török, Bibiána (Biológus), szerző] Molekuláris Farmakológia Kutatócsoport (HRN KOKI); Kísérleti Orvostudományi Kutatóintézet 4 0.1 false false false Author 10066202 /api/author/10066202 Szocsics-Török Bibiána (Biológus) Szocsics-Török Bibiána true true Török Bibiana true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 109675868 /api/authorship/109675868 Brunner, János [Brunner, János (Neurofarmakológia), szerző] Celluláris Neurofarmakológia Kutatócsoport (HRN KOKI); Kísérleti Orvostudományi Kutatóintézet 5 0.1 false false false Author 10014148 /api/author/10014148 Brunner János (Neurofarmakológia) Brunner János true 10014148 true Brunner János true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 109675869 /api/authorship/109675869 Arszovszki, Antonia [Arszovszki, Antónia (Neurobiológia), szerző] Celluláris Neurofarmakológia Kutatócsoport (HRN KOKI); Kísérleti Orvostudományi Kutatóintézet 6 0.1 false false false Author 156 /api/author/156 Arszovszki Antónia (Neurobiológia) Arszovszki Antónia true 156 true Arszovszki Antonia true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 109675870 /api/authorship/109675870 Iring, András [Iring, András (Élettan), szerző] Molekuláris Farmakológia Kutatócsoport (HRN KOKI); Kísérleti Orvostudományi Kutatóintézet 7 0.1 false false false Author 10032256 /api/author/10032256 Iring András (Élettan) Iring András true 10032256 true Iring András true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 109675871 /api/authorship/109675871 Kisfali, Máté [Kisfali, Máté (biológia), szerző] Molekuláris Neurobiológiai Kutatócsoport (HRN KOKI) 8 0.1 false false false Author 10032152 /api/author/10032152 Kisfali Máté (biológia) Kisfali Máté true 10032152 true Kisfali Máté true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 109675872 /api/authorship/109675872 Vizi, E. Sylvester [Vizi, E. Szilveszter (Neurofarmakológia...), szerző] Doktori Iskola (SE); Molekuláris Farmakológia Kutatócsoport (HRN KOKI); Kísérleti Orvostudományi Kutatóintézet 9 0.1 false false false Author 10000023 /api/author/10000023 Vizi E. Szilveszter (Neurofarmakológia, neurokémia) Vizi E. Szilveszter true 10000023 true Vizi E. Sylvester true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PersonAuthorship 109675873 /api/authorship/109675873 Sperlágh, Beáta ✉ [Sperlágh, Beáta (Neurofarmakológia), szerző] Doktori Iskola (SE); Molekuláris Farmakológia Kutatócsoport (HRN KOKI); Kísérleti Orvostudományi Kutatóintézet 10 0.1 false true true Author 10008942 /api/author/10008942 Sperlágh Beáta (Neurofarmakológia) Sperlágh Beáta true 10008942 true Sperlágh Beáta true false false AuthorshipType 1 /api/authorshiptype/1 Szerző 0 true 0 true false true PublicationIdentifier 24295304 /api/publicationidentifier/24295304 DOI: 10.1016/j.isci.2023.107560 PlainSource 6 /api/publicationsource/6 DOI PublicationSourceType 10001 /api/publicationsourcetype/10001 DOI true true true DOI DOI https://doi.org/@@@ true true 6 true GREEN true IDENTICAL 10.1016/j.isci.2023.107560 https://doi.org/10.1016/j.isci.2023.107560 false true PublicationIdentifier 24295311 /api/publicationidentifier/24295311 REAL: 172000 SwordSource 36 /api/publicationsource/36 REAL PublicationSourceType 10007 /api/publicationsourcetype/10007 Repozitórium true true true REAL REAL https://real.mtak.hu/@@@ true true 36 true GREEN true IDENTICAL 172000 https://real.mtak.hu/172000 false true PublicationIdentifier 25460426 /api/publicationidentifier/25460426 WoS: 001144704000001 PlainSource 1 /api/publicationsource/1 WoS PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true WoS WoS https://www.webofscience.com/wos/woscc/full-record/@@@ true true 1 true IDENTICAL 001144704000001 https://www.webofscience.com/wos/woscc/full-record/001144704000001 true true PublicationIdentifier 24310770 /api/publicationidentifier/24310770 Scopus: 85167989371 PlainSource 3 /api/publicationsource/3 Scopus PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true Scopus Scopus http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-@@@ true true 3 true IDENTICAL 85167989371 http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-85167989371 true true PublicationIdentifier 24897039 /api/publicationidentifier/24897039 PubMed: 37649698 PlainSource 17 /api/publicationsource/17 PubMed PublicationSourceType 10003 /api/publicationsourcetype/10003 Indexelő adatbázis false true true PubMed PubMed http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=@@@&dopt=Abstract true true 17 true IDENTICAL 37649698 http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=37649698&dopt=Abstract true true SjrRating 11400895 /api/sjrrating/11400895 sjr:D1 (2023) Scopus - Multidisciplinary ISCIENCE 2589-0042 12 0.1 journal RatingType 10002 /api/ratingtype/10002 sjr sjr true true ClassificationExternal 1000 /api/classificationexternal/1000 Scopus - Multidisciplinary true 1000 true D1 DIRECT true true Reference 44561236 /api/reference/44561236 1. Cheffer 2018: Purinergic system in psychiatric diseases., Mol. Psychiatry, 23, p. 94, DOI: 10.1038/mp.2017.188 1 10.1038/mp.2017.188 false true Reference 44561237 /api/reference/44561237 2. Andrejew 2020: The P2X7 Receptor: Central Hub of Brain Diseases., Front. Mol. Neurosci., 13, p. 124, DOI: 10.3389/fnmol.2020.00124 2 10.3389/fnmol.2020.00124 false true Reference 44561238 /api/reference/44561238 3. Miras-Portugal 2017: Neuronal P2X7 Receptor: Involvement in Neuronal Physiology and Pathology., J. Neurosci., 37, p. 7063, DOI: 10.1523/JNEUROSCI.3104-16.2017 3 10.1523/JNEUROSCI.3104-16.2017 false true Reference 44561239 /api/reference/44561239 4. Illes 2017: Neuronal P2X7 Receptors Revisited: Do They Really Exist?., J. Neurosci., 37, p. 7049, DOI: 10.1523/JNEUROSCI.3103-16.2017 4 10.1523/JNEUROSCI.3103-16.2017 false true Reference 44561240 /api/reference/44561240 5. Yu 2008: Cellular localization of P2X7 receptor mRNA in the rat brain., Brain Res., 1194, p. 45, DOI: 10.1016/j.brainres.2007.11.064 5 10.1016/j.brainres.2007.11.064 false true Reference 44561241 /api/reference/44561241 6. Metzger 2017: Heterozygosity for the Mood Disorder-Associated Variant Gln460Arg Alters P2X7 Receptor Function and Sleep Quality., J. Neurosci., 37, p. 11688, DOI: 10.1523/JNEUROSCI.3487-16.2017 6 10.1523/JNEUROSCI.3487-16.2017 false true Reference 44561242 /api/reference/44561242 7. Hodge 2019: Conserved cell types with divergent features in human versus mouse cortex., Nature, 573, p. 61, DOI: 10.1038/s41586-019-1506-7 7 10.1038/s41586-019-1506-7 false true Reference 44561243 /api/reference/44561243 8. Sperlágh 2002: Involvement of P2X7 receptors in the regulation of neurotransmitter release in the rat hippocampus., J. Neurochem., 81, p. 1196, DOI: 10.1046/j.1471-4159.2002.00920.x 8 10.1046/j.1471-4159.2002.00920.x false true Reference 44561244 /api/reference/44561244 9. Papp 2004: Lack of ATP-evoked GABA and glutamate release in the hippocampus of P2X7 receptor-/- mice., Neuroreport, 15, p. 2387, DOI: 10.1097/00001756-200410250-00017 9 10.1097/00001756-200410250-00017 false true Reference 44561245 /api/reference/44561245 10. Cho 2010: P2X7 receptors enhance glutamate release in hippocampal hilar neurons., Neuroreport, 21, p. 865, DOI: 10.1097/WNR.0b013e32833d9142 10 10.1097/WNR.0b013e32833d9142 false true Reference 44561246 /api/reference/44561246 11. Khan 2019: Astrocytic rather than neuronal P2X7 receptors modulate the function of the tri-synaptic network in the rodent hippocampus., Brain Res. Bull., 151, p. 164, DOI: 10.1016/j.brainresbull.2018.07.016 11 10.1016/j.brainresbull.2018.07.016 false true Reference 44561247 /api/reference/44561247 12. Uno 2019: Glutamate hypothesis in schizophrenia., Psychiatry Clin. Neurosci., 73, p. 204, DOI: 10.1111/pcn.12823 12 10.1111/pcn.12823 false true Reference 44561248 /api/reference/44561248 13. Trubetskoy 2022: Mapping genomic loci implicates genes and synaptic biology in schizophrenia., Nature, 604, p. 502, DOI: 10.1038/s41586-022-04434-5 13 10.1038/s41586-022-04434-5 false true Reference 44561249 /api/reference/44561249 14. Koványi 2016: The role of P2X7 receptors in a rodent PCP-induced schizophrenia model., Sci. Rep., 6, DOI: 10.1038/srep36680 14 10.1038/srep36680 false true Reference 44561250 /api/reference/44561250 15. Calovi 2020: P2X7 Receptor-Dependent Layer-Specific Changes in Neuron-Microglia Reactivity in the Prefrontal Cortex of a Phencyclidine Induced Mouse Model of Schizophrenia., Front. Mol. Neurosci., 13, DOI: 10.3389/fnmol.2020.566251 15 10.3389/fnmol.2020.566251 false true Reference 44561251 /api/reference/44561251 16. Grayson 2016: Postnatal Phencyclidine (PCP) as a Neurodevelopmental Animal Model of Schizophrenia Pathophysiology and Symptomatology: A Review., Curr. Top. Behav. Neurosci., 29, p. 403, DOI: 10.1007/7854_2015_403 16 10.1007/7854_2015_403 false true Reference 44561252 /api/reference/44561252 17. Huang 2021: The potential of the P2X7 receptor as a therapeutic target in a sub-chronic PCP-induced rodent model of schizophrenia., J. Chem. Neuroanat., 116, DOI: 10.1016/j.jchemneu.2021.101993 17 10.1016/j.jchemneu.2021.101993 false true Reference 44561253 /api/reference/44561253 18. Ireland 2004: P2X7-like receptor subunits enhance excitatory synaptic transmission at central synapses by presynaptic mechanisms., Neuroscience, 128, p. 269, DOI: 10.1016/j.neuroscience.2004.06.014 18 10.1016/j.neuroscience.2004.06.014 false true Reference 44561254 /api/reference/44561254 19. Wong 2006: Endogenous activation of adenosine A1 receptors, but not P2X receptors, during high-frequency synaptic transmission at the calyx of Held., J. Neurophysiol., 95, p. 3336, DOI: 10.1152/jn.00694.2005 19 10.1152/jn.00694.2005 false true Reference 44561255 /api/reference/44561255 20. Montilla 2020: Contribution of P2X4 Receptors to CNS Function and Pathophysiology., Int. J. Mol. Sci., 21, DOI: 10.3390/ijms21155562 20 10.3390/ijms21155562 false true Reference 44561256 /api/reference/44561256 21. Stokes 2017: P2X4 Receptor Function in the Nervous System and Current Breakthroughs in Pharmacology., Front. Pharmacol., 8, p. 291, DOI: 10.3389/fphar.2017.00291 21 10.3389/fphar.2017.00291 false true Reference 44561257 /api/reference/44561257 22. Weinhold 2010: Interaction and interrelation of P2X7 and P2X4 receptor complexes in mouse lung epithelial cells., Cell. Mol. Life Sci., 67, p. 2631, DOI: 10.1007/s00018-010-0355-1 22 10.1007/s00018-010-0355-1 false true Reference 44561258 /api/reference/44561258 23. Schneider 2017: Interaction of Purinergic P2X4 and P2X7 Receptor Subunits., Front. Pharmacol., 8, p. 860, DOI: 10.3389/fphar.2017.00860 23 10.3389/fphar.2017.00860 false true Reference 44561259 /api/reference/44561259 24. Guo 2007: Evidence for functional P2X4/P2X7 heteromeric receptors., Mol. Pharmacol., 72, p. 1447, DOI: 10.1124/mol.107.035980 24 10.1124/mol.107.035980 false true Reference 44561260 /api/reference/44561260 25. Hashimotodani 2017: LTP at Hilar Mossy Cell-Dentate Granule Cell Synapses Modulates Dentate Gyrus Output by Increasing Excitation/Inhibition Balance., Neuron, 95, p. 928, DOI: 10.1016/j.neuron.2017.07.028 25 10.1016/j.neuron.2017.07.028 false true Reference 44561261 /api/reference/44561261 26. Tabuchi 2022: Excitatory selective LTP of supramammillary glutamatergic/GABAergic cotransmission potentiates dentate granule cell firing., Proc. Natl. Acad. Sci. USA., 119, DOI: 10.1073/pnas.2119636119 26 10.1073/pnas.2119636119 false true Reference 44561262 /api/reference/44561262 27. Li 2020: Supramammillary nucleus synchronizes with dentate gyrus to regulate spatial memory retrieval through glutamate release., Elife, 9 27 false true Reference 44561263 /api/reference/44561263 28. Chiu 2008: Input-specific plasticity at excitatory synapses mediated by endocannabinoids in the dentate gyrus., Neuropharmacology, 54, p. 68, DOI: 10.1016/j.neuropharm.2007.06.026 28 10.1016/j.neuropharm.2007.06.026 false true Reference 44561264 /api/reference/44561264 29. Qian 2001: Presynaptic Ca2+ channels and neurotransmitter release at the terminal of a mouse cortical neuron., J. Neurosci., 21, p. 3721, DOI: 10.1523/JNEUROSCI.21-11-03721.2001 29 10.1523/JNEUROSCI.21-11-03721.2001 false true Reference 44561265 /api/reference/44561265 30. Wang 2001: Long-term behavioral and neurodegenerative effects of perinatal phencyclidine administration: implications for schizophrenia., Neuroscience, 107, p. 535, DOI: 10.1016/S0306-4522(01)00384-0 30 10.1016/S0306-4522(01)00384-0 false true Reference 44561266 /api/reference/44561266 31. Veleanu 2022: Modified climbing fiber/Purkinje cell synaptic connectivity in the cerebellum of the neonatal phencyclidine model of schizophrenia., Proc. Natl. Acad. Sci. USA, 119, DOI: 10.1073/pnas.2122544119 31 10.1073/pnas.2122544119 false true Reference 44561267 /api/reference/44561267 32. Ziermans 2011: Reduced prepulse inhibition in adolescents at risk for psychosis: a 2-year follow-up study., J. Psychiatry Neurosci., 36, p. 127, DOI: 10.1503/jpn.100063 32 10.1503/jpn.100063 false true Reference 44561268 /api/reference/44561268 33. Yang 2017: Deficits of perceived spatial separation induced prepulse inhibition in patients with schizophrenia: relationships to symptoms and neurocognition., BMC Psychiatr., 17, p. 135, DOI: 10.1186/s12888-017-1276-4 33 10.1186/s12888-017-1276-4 false true Reference 44561269 /api/reference/44561269 34. Bo 2021: Impaired Sensorimotor Gating Using the Acoustic Prepulse Inhibition Paradigm in Individuals at a Clinical High Risk for Psychosis., Schizophr. Bull., 47, p. 128, DOI: 10.1093/schbul/sbaa102 34 10.1093/schbul/sbaa102 false true Reference 44561270 /api/reference/44561270 35. Li 2021: Pre-pulse inhibition deficits in individuals at clinical high-risk for psychosis: A systematic review and meta-analysis., Early Interv. Psychiatry, 15, p. 794, DOI: 10.1111/eip.13015 35 10.1111/eip.13015 false true Reference 44561271 /api/reference/44561271 36. Spielewoy 2004: Strain-specificity in nicotine attenuation of phencyclidine-induced disruption of prepulse inhibition in mice: relevance to smoking in schizophrenia patients., Behav. Genet., 34, p. 343, DOI: 10.1023/B:BEGE.0000017878.75206.fd 36 10.1023/B:BEGE.0000017878.75206.fd false true Reference 44561272 /api/reference/44561272 37. Yuede 2010: Behavioral consequences of NMDA antagonist-induced neuroapoptosis in the infant mouse brain., PLoS One, 5, DOI: 10.1371/journal.pone.0011374 37 10.1371/journal.pone.0011374 false true Reference 44561273 /api/reference/44561273 38. Armstrong 2002: Activation of presynaptic P2X7-like receptors depresses mossy fiber-CA3 synaptic transmission through p38 mitogen-activated protein kinase., J. Neurosci., 22, p. 5938, DOI: 10.1523/JNEUROSCI.22-14-05938.2002 38 10.1523/JNEUROSCI.22-14-05938.2002 false true Reference 44561274 /api/reference/44561274 39. Kukley 2004: Ecto-nucleotidases and nucleoside transporters mediate activation of adenosine receptors on hippocampal mossy fibers by P2X7 receptor agonist 2'-3'-O-(4-benzoylbenzoyl)-ATP., J. Neurosci., 24, p. 7128, DOI: 10.1523/JNEUROSCI.2093-04.2004 39 10.1523/JNEUROSCI.2093-04.2004 false true Reference 44561275 /api/reference/44561275 40. Illes 2021: Update of P2X receptor properties and their pharmacology: IUPHAR Review 30., Br. J. Pharmacol., 178, p. 489, DOI: 10.1111/bph.15299 40 10.1111/bph.15299 false true Reference 44561276 /api/reference/44561276 41. Wildman 2003: Extended pharmacological profiles of rat P2Y2 and rat P2Y4 receptors and their sensitivity to extracellular H+ and Zn2+ ions., Br. J. Pharmacol., 140, p. 1177, DOI: 10.1038/sj.bjp.0705544 41 10.1038/sj.bjp.0705544 false true Reference 44561277 /api/reference/44561277 42. Mikolajewicz 2021: High-affinity P2Y2 and low-affinity P2X7 receptor interaction modulates ATP-mediated calcium signaling in murine osteoblasts., PLoS Comput. Biol., 17, DOI: 10.1371/journal.pcbi.1008872 42 10.1371/journal.pcbi.1008872 false true Reference 44561278 /api/reference/44561278 43. Supłat-Wypych 2010: 2', 3'-O-(4-benzoylbenzoyl)-ATP-mediated calcium signaling in rat glioma C6 cells: role of the P2Y(2) nucleotide receptor., Purinergic Signal., 6, p. 317, DOI: 10.1007/s11302-010-9194-7 43 10.1007/s11302-010-9194-7 false true Reference 44561279 /api/reference/44561279 44. Hracskó 2011: Lack of neuroprotection in the absence of P2X7 receptors in toxin-induced animal models of Parkinson's disease., Mol. Neurodegener., 6, p. 28, DOI: 10.1186/1750-1326-6-28 44 10.1186/1750-1326-6-28 false true Reference 44561280 /api/reference/44561280 45. Baxter 2011: Role of P2X4 receptors in synaptic strengthening in mouse CA1 hippocampal neurons., Eur. J. Neurosci., 34, p. 213, DOI: 10.1111/j.1460-9568.2011.07763.x 45 10.1111/j.1460-9568.2011.07763.x false true Reference 44561281 /api/reference/44561281 46. Sim 2006: Altered hippocampal synaptic potentiation in P2X4 knock-out mice., J. Neurosci., 26, p. 9006, DOI: 10.1523/JNEUROSCI.2370-06.2006 46 10.1523/JNEUROSCI.2370-06.2006 false true Reference 44561282 /api/reference/44561282 47. Nicke 2009: A functional P2X7 splice variant with an alternative transmembrane domain 1 escapes gene inactivation in P2X7 knock-out mice., J. Biol. Chem., 284, p. 25813, DOI: 10.1074/jbc.M109.033134 47 10.1074/jbc.M109.033134 false true Reference 44561283 /api/reference/44561283 48. Marín-García 2008: Synaptic terminals from mice midbrain exhibit functional P2X7 receptor., Neuroscience, 151, p. 361, DOI: 10.1016/j.neuroscience.2007.10.038 48 10.1016/j.neuroscience.2007.10.038 false true Reference 44561284 /api/reference/44561284 49. Yan 2011: Calcium-dependent block of P2X7 receptor channel function is allosteric., J. Gen. Physiol., 138, p. 437, DOI: 10.1085/jgp.201110647 49 10.1085/jgp.201110647 false true Reference 44561285 /api/reference/44561285 50. Bartlett 2013: P2X7 receptor activation induces reactive oxygen species formation and cell death in murine EOC13 microglia., Mediators Inflamm., 2013, DOI: 10.1155/2013/271813 50 10.1155/2013/271813 false true Reference 44561286 /api/reference/44561286 51. Zhang 2022: ATP indirectly stimulates hippocampal CA1 and CA3 pyramidal neurons via the activation of neighboring P2X7 receptor-bearing astrocytes and NG2 glial cells, respectively., Front. Pharmacol., 13 51 false true Reference 44561287 /api/reference/44561287 52. Ding 2016: Changes in the composition of brain interstitial ions control the sleep-wake cycle., Science, 352, p. 550, DOI: 10.1126/science.aad4821 52 10.1126/science.aad4821 false true Reference 44561288 /api/reference/44561288 53. Silver 1990: Intracellular and extracellular changes of [Ca2+] in hypoxia and ischemia in rat brain in vivo., J. Gen. Physiol., 95, p. 837, DOI: 10.1085/jgp.95.5.837 53 10.1085/jgp.95.5.837 false true Reference 44561289 /api/reference/44561289 54. Jones 1988: Brain fluid calcium concentration and response to acute hypercalcaemia during development in the rat., J. Physiol., 402, p. 579, DOI: 10.1113/jphysiol.1988.sp017223 54 10.1113/jphysiol.1988.sp017223 false true Reference 44561290 /api/reference/44561290 55. Vance 2015: PAR1-activated astrocytes in the nucleus of the solitary tract stimulate adjacent neurons via NMDA receptors., J. Neurosci., 35, p. 776, DOI: 10.1523/JNEUROSCI.3105-14.2015 55 10.1523/JNEUROSCI.3105-14.2015 false true Reference 44561291 /api/reference/44561291 56. Colino 1993: Mechanisms underlying induction of long-term potentiation in rat medial and lateral perforant paths in vitro., J. Neurophysiol., 69, p. 1150, DOI: 10.1152/jn.1993.69.4.1150 56 10.1152/jn.1993.69.4.1150 false true Reference 44561292 /api/reference/44561292 57. Macek 1996: Differential involvement of group II and group III mGluRs as autoreceptors at lateral and medial perforant path synapses., J. Neurophysiol., 76, p. 3798, DOI: 10.1152/jn.1996.76.6.3798 57 10.1152/jn.1996.76.6.3798 false true Reference 44561293 /api/reference/44561293 58. McNaughton 1980: Evidence for two physiologically distinct perforant pathways to the fascia dentata., Brain Res., 199, p. 1, DOI: 10.1016/0006-8993(80)90226-7 58 10.1016/0006-8993(80)90226-7 false true Reference 44561294 /api/reference/44561294 59. Suzuki 2011: The facilitative effects of bilobalide, a unique constituent of Ginkgo biloba, on synaptic transmission and plasticity in hippocampal subfields., J. Physiol. Sci., 61, p. 421, DOI: 10.1007/s12576-011-0159-6 59 10.1007/s12576-011-0159-6 false true Reference 44561295 /api/reference/44561295 60. Petersen 2013: Electrophysiological identification of medial and lateral perforant path inputs to the dentate gyrus., Neuroscience, 252, p. 154, DOI: 10.1016/j.neuroscience.2013.07.063 60 10.1016/j.neuroscience.2013.07.063 false true Reference 44561296 /api/reference/44561296 61. Mut-Arbona 2023: Dual Role of the P2X7 Receptor in Dendritic Outgrowth during Physiological and Pathological Brain Development., J. Neurosci., 43, p. 1125, DOI: 10.1523/JNEUROSCI.0805-22.2022 61 10.1523/JNEUROSCI.0805-22.2022 false true Reference 44561297 /api/reference/44561297 62. Sebastián-Serrano 2016: Neurodevelopmental alterations and seizures developed by mouse model of infantile hypophosphatasia are associated with purinergic signalling deregulation., Hum. Mol. Genet., 25, p. 4143, DOI: 10.1093/hmg/ddw248 62 10.1093/hmg/ddw248 false true Reference 44561298 /api/reference/44561298 63. Mitchell 2020: Temporal dissociation of phencyclidine: Induced locomotor and social alterations in rats using an automated homecage monitoring system - implications for the 3Rs and preclinical drug discovery., J. Psychopharmacol., 34, p. 709, DOI: 10.1177/0269881120920455 63 10.1177/0269881120920455 false true Reference 44561299 /api/reference/44561299 64. Bujas-Bobanovic 2000: Blockade of phencyclidine-induced effects by a nitric oxide donor., Br. J. Pharmacol., 130, p. 1005, DOI: 10.1038/sj.bjp.0703406 64 10.1038/sj.bjp.0703406 false true Reference 44561300 /api/reference/44561300 65. Grillon 1992: Startle gating deficits occur across prepulse intensities in schizophrenic patients., Biol. Psychiatry, 32, p. 939, DOI: 10.1016/0006-3223(92)90183-Z 65 10.1016/0006-3223(92)90183-Z false true Reference 44561301 /api/reference/44561301 66. Weike 2000: Effective neuroleptic medication removes prepulse inhibition deficits in schizophrenia patients., Biol. Psychiatry, 47, p. 61, DOI: 10.1016/S0006-3223(99)00229-2 66 10.1016/S0006-3223(99)00229-2 false true Reference 44561302 /api/reference/44561302 67. Braff 2005: Female schizophrenia patients have prepulse inhibition deficits., Biol. Psychiatry, 57, p. 817, DOI: 10.1016/j.biopsych.2004.12.030 67 10.1016/j.biopsych.2004.12.030 false true Reference 44561303 /api/reference/44561303 68. Mena 2016: Reduced Prepulse Inhibition as a Biomarker of Schizophrenia., Front. Behav. Neurosci., 10, p. 202, DOI: 10.3389/fnbeh.2016.00202 68 10.3389/fnbeh.2016.00202 false true Reference 44561304 /api/reference/44561304 69. Swerdlow 2014: Deficient prepulse inhibition in schizophrenia detected by the multi-site COGS., Schizophr. Res., 152, p. 503, DOI: 10.1016/j.schres.2013.12.004 69 10.1016/j.schres.2013.12.004 false true Reference 44561305 /api/reference/44561305 70. Martinez 1999: Effects of sustained phencyclidine exposure on sensorimotor gating of startle in rats., Neuropsychopharmacology, 21, p. 28, DOI: 10.1016/S0893-133X(98)00137-7 70 10.1016/S0893-133X(98)00137-7 false true Reference 44561306 /api/reference/44561306 71. Andreasen 2006: Nicotine and clozapine selectively reverse a PCP-induced deficit of PPI in BALB/cByJ but not NMRI mice: comparison with risperidone., Behav. Brain Res., 167, p. 118, DOI: 10.1016/j.bbr.2005.08.023 71 10.1016/j.bbr.2005.08.023 false true Reference 44561307 /api/reference/44561307 72. Kjaerby 2013: Repeated potentiation of the metabotropic glutamate receptor 5 and the alpha 7 nicotinic acetylcholine receptor modulates behavioural and GABAergic deficits induced by early postnatal phencyclidine (PCP) treatment., Neuropharmacology, 72, p. 157, DOI: 10.1016/j.neuropharm.2013.04.041 72 10.1016/j.neuropharm.2013.04.041 false true Reference 44561308 /api/reference/44561308 73. Maple 2017: Effects of Repeated Ropinirole Treatment on Phencyclidine-Induced Hyperlocomotion, Prepulse Inhibition Deficits, and Social Avoidance in Rats., J. Pharmacol. Exp. Ther., 361, p. 109, DOI: 10.1124/jpet.116.238634 73 10.1124/jpet.116.238634 false true Reference 44561309 /api/reference/44561309 74. McCutcheon 2023: Cognitive impairment in schizophrenia: aetiology, pathophysiology, and treatment., Mol. Psychiatry 74 false true Reference 44561310 /api/reference/44561310 75. Kristóf 2022: Elevated Serum Purine Levels in Schizophrenia: A Reverse Translational Study to Identify Novel Inflammatory Biomarkers., Int. J. Neuropsychopharmacol., 25, p. 645, DOI: 10.1093/ijnp/pyac026 75 10.1093/ijnp/pyac026 false true Reference 44561311 /api/reference/44561311 76. Horváth 2019: P2X7 Receptors Drive Poly(I:C) Induced Autism-like Behavior in Mice., J. Neurosci., 39, p. 2542 76 false true Reference 44561312 /api/reference/44561312 77. Kasanetz 2009: Maturation of excitatory synaptic transmission of the rat nucleus accumbens from juvenile to adult., J. Neurophysiol., 101, p. 2516, DOI: 10.1152/jn.91039.2008 77 10.1152/jn.91039.2008 false true Reference 44561313 /api/reference/44561313 78. Miwa 2011: Neural systems governed by nicotinic acetylcholine receptors: emerging hypotheses., Neuron, 70, p. 20, DOI: 10.1016/j.neuron.2011.03.014 78 10.1016/j.neuron.2011.03.014 false true Reference 44561314 /api/reference/44561314 79. Martin 2014: Late onset deficits in synaptic plasticity in the valproic acid rat model of autism., Front. Cell. Neurosci., 8, p. 23, DOI: 10.3389/fncel.2014.00023 79 10.3389/fncel.2014.00023 false true Reference 44561315 /api/reference/44561315 80. Tang 2015: Modulation of AMPA receptor mediated current by nicotinic acetylcholine receptor in layer I neurons of rat prefrontal cortex., Sci. Rep., 5, DOI: 10.1038/srep14099 80 10.1038/srep14099 false true Reference 44561316 /api/reference/44561316 81. Naviaux 2013: Antipurinergic therapy corrects the autism-like features in the poly(IC) mouse model., PLoS One, 8, DOI: 10.1371/journal.pone.0057380 81 10.1371/journal.pone.0057380 false true /api/publication/34109310 Huang Lumei et al. P2X7 purinergic receptor modulates dentate gyrus excitatory neurotransmission and alleviates schizophrenia-like symptoms in mouse. (2023) ISCIENCE 2589-0042 26 9<div class="JournalArticle Publication long-list"> <div class="authors"> <img title="Forrásközlemény" style="float: left" src="/frontend/resources/grid/publication-core-icon.png"> <img title="Idézőközlemény" style="float: left" src="/frontend/resources/grid/publication-citation-icon.png"> <div class="autype autype0"> <span class="author-name" mtid="10070293"><a href="/gui2/?type=authors&mode=browse&sel=10070293" target="_blank">Huang Lumei (<span class="authorship-author-name">Huang Lumei</span> <span class="authorAux-mtmt"> Institute of experimental medicine</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/Doktori Iskola; <span title="Kísérleti Orvostudományi Kutatóintézet">KOKI</span>/Molekuláris Farmakológia Kutatócsoport; Kísérleti Orvostudományi Kutatóintézet</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10071685"><a href="/gui2/?type=authors&mode=browse&sel=10071685" target="_blank">Mut-Arbona Paula (<span class="authorship-author-name">Mut-Arbona Paula</span> <span class="authorAux-mtmt"> Neuroscience</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/Doktori Iskola; <span title="Kísérleti Orvostudományi Kutatóintézet">KOKI</span>/Molekuláris Farmakológia Kutatócsoport; Kísérleti Orvostudományi Kutatóintézet</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10076833"><a href="/gui2/?type=authors&mode=browse&sel=10076833" target="_blank">Varga Bernadett (<span class="authorship-author-name">Iring-Varga Bernadett</span> <span class="authorAux-mtmt"> funkcionális idegtudomány</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/Doktori Iskola; <span title="Kísérleti Orvostudományi Kutatóintézet">KOKI</span>/Molekuláris Farmakológia Kutatócsoport; Kísérleti Orvostudományi Kutatóintézet</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10066202"><a href="/gui2/?type=authors&mode=browse&sel=10066202" target="_blank">Török Bibiana (<span class="authorship-author-name">Szocsics-Török Bibiána</span> <span class="authorAux-mtmt"> Biológus</span>) </a> </span> <span class="author-affil"><span title="Kísérleti Orvostudományi Kutatóintézet">KOKI</span>/Molekuláris Farmakológia Kutatócsoport; Kísérleti Orvostudományi Kutatóintézet</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10014148"><a href="/gui2/?type=authors&mode=browse&sel=10014148" target="_blank">Brunner János (<span class="authorship-author-name">Brunner János</span> <span class="authorAux-mtmt"> Neurofarmakológia</span>) </a> </span> <span class="author-affil"><span title="Kísérleti Orvostudományi Kutatóintézet">KOKI</span>/Celluláris Neurofarmakológia Kutatócsoport; Kísérleti Orvostudományi Kutatóintézet</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="156"><a href="/gui2/?type=authors&mode=browse&sel=156" target="_blank">Arszovszki Antonia (<span class="authorship-author-name">Arszovszki Antónia</span> <span class="authorAux-mtmt"> Neurobiológia</span>) </a> </span> <span class="author-affil"><span title="Kísérleti Orvostudományi Kutatóintézet">KOKI</span>/Celluláris Neurofarmakológia Kutatócsoport; Kísérleti Orvostudományi Kutatóintézet</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10032256"><a href="/gui2/?type=authors&mode=browse&sel=10032256" target="_blank">Iring András (<span class="authorship-author-name">Iring András</span> <span class="authorAux-mtmt"> Élettan</span>) </a> </span> <span class="author-affil"><span title="Kísérleti Orvostudományi Kutatóintézet">KOKI</span>/Molekuláris Farmakológia Kutatócsoport; Kísérleti Orvostudományi Kutatóintézet</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10032152"><a href="/gui2/?type=authors&mode=browse&sel=10032152" target="_blank">Kisfali Máté (<span class="authorship-author-name">Kisfali Máté</span> <span class="authorAux-mtmt"> biológia</span>) </a> </span> <span class="author-affil"><span title="Kísérleti Orvostudományi Kutatóintézet">KOKI</span>/Molekuláris Neurobiológiai Kutatócsoport</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10000023"><a href="/gui2/?type=authors&mode=browse&sel=10000023" target="_blank">Vizi E. Sylvester (<span class="authorship-author-name">Vizi E. Szilveszter</span> <span class="authorAux-mtmt"> Neurofarmakológia, neurokémia</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/Doktori Iskola; <span title="Kísérleti Orvostudományi Kutatóintézet">KOKI</span>/Molekuláris Farmakológia Kutatócsoport; Kísérleti Orvostudományi Kutatóintézet</span> ;&nbsp;&nbsp;&nbsp; <span class="author-name" mtid="10008942"><a href="/gui2/?type=authors&mode=browse&sel=10008942" target="_blank">Sperlágh Beáta ✉ (<span class="authorship-author-name">Sperlágh Beáta</span> <span class="authorAux-mtmt"> Neurofarmakológia</span>) </a> </span> <span class="author-affil"><span title="Semmelweis Egyetem">SE</span>/Doktori Iskola; <span title="Kísérleti Orvostudományi Kutatóintézet">KOKI</span>/Molekuláris Farmakológia Kutatócsoport; Kísérleti Orvostudományi Kutatóintézet</span> </div> </div> <div class="title"><a href="/gui2/?mode=browse&params=publication;34109310" target="_blank">P2X7 purinergic receptor modulates dentate gyrus excitatory neurotransmission and alleviates schizophrenia-like symptoms in mouse</a></div> <div> <span class="journal-title">ISCIENCE</span> <span class="journal-issn">( <a target="_blank" href="https://portal.issn.org/resource/ISSN/2589-0042">2589-0042</a>)</span>: <span class="journal-volume">26</span> <span class="journal-issue">9</span> <span class="page"> Paper 107560. 24 p. </span> <span class="year">(2023)</span> </div> <div class="pub-footer"> <span class="language" xmlns="http://www.w3.org/1999/html">Nyelv: Angol | </span> <span class="identifiers"> <span class="id identifier oa_GREEN" title=" Green "> <a style="color:blue" title="10.1016/j.isci.2023.107560" target="_blank" href="https://doi.org/10.1016/j.isci.2023.107560"> DOI </a> </span> <span class="id identifier oa_GREEN" title=" Green "> <a style="color:blue" title="172000" target="_blank" href="https://real.mtak.hu/172000"> REAL </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="001144704000001" target="_blank" href="https://www.webofscience.com/wos/woscc/full-record/001144704000001"> WoS </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="85167989371" target="_blank" href="http://www.scopus.com/record/display.url?origin=inward&eid=2-s2.0-85167989371"> Scopus </a> </span> <span class="id identifier oa_none" title="none"> <a style="color:blue" title="37649698" target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=37649698&dopt=Abstract"> PubMed </a> </span> </span> <OnlyViewableByAuthor><div class="ratings"> <div class="journal-subject">Folyóirat szakterülete: Scopus - Multidisciplinary&nbsp;&nbsp;&nbsp;SJR indikátor:&nbsp;D1</div> </div></OnlyViewableByAuthor> <div class="publication-citation" style="margin-left: 0.5cm;"> <span title="Nyilvános idézőközlemények összesen, említések nélkül" class="citingPub-count">Nyilvános idéző összesen: 9</span> | Független: 9 | Függő: 0 | Nem jelölt: 0 | WoS jelölt: 8 | Scopus jelölt:&nbsp;9 | WoS/Scopus jelölt:&nbsp;9 | DOI jelölt:&nbsp;9 </div> <div class="publication-citation"> <a target="_blank" href="/api/publication?cond=citations.related;eq;34109310&sort=publishedYear,desc&sort=title"> Idézett közlemények száma: 10 </a> </div> <div class="mtid"><span class="long-pub-mtid">Közlemény: 34109310</span> | <span class="status-data status-VALIDATED"> Egyeztetett </span> Forrás Idéző | <span class="type-subtype">Folyóiratcikk ( Szakcikk ) </span> | <span class="pub-category">Tudományos</span> | <span class="publication-sourceOfData">kézi felvitel</span> </div> <div class="funder"> Nemzeti Gyógyszerkutatási és Fejlesztési Laboratórium (PharmaLab)(RRF-2.3.1-21-2022-00015) Támogató: NKFIH, National Laboratory of Translational Neuroscience (TINL)(RRF-2.3.1-21-2022-00011), Recovery and Resilience Facility of the European Union within the framework of Programme Szécheny...(RRF-2.3.1-21-2022-00011), National Laboratory of Translational Neuroscience (TINL)(RRF-2.3.1-21-2022-00011), Hungarian Research and Development Fund(131629), Hungarian Brain Research Program(NAP2022-I-1/2022), European Union’s Horizon 2020 Research and Innovation Program under the Marie Skłodowska Curie(766124) </div> <div class="lastModified">Utolsó módosítás: 2024.04.17. 16:12 Lévayné Deseő Katalin (MTMT Központi admin) </div> <div class="lockedBy">Központi kezelésű 2024.10.17. 18:20 Nemec Évi (MTMT Központi 3, admin) Ladányi Gusztáv (MTMT API user, admin) </div> </div></div>